These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 11517161

  • 21. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
    Tsai HW, Katzenellenbogen JA, Katzenellenbogen BS, Shupnik MA.
    Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
    [Abstract] [Full Text] [Related]

  • 22. Role of systemic and local IGF-I in the effects of estrogen on growth and epithelial proliferation of mouse uterus.
    Sato T, Wang G, Hardy MP, Kurita T, Cunha GR, Cooke PS.
    Endocrinology; 2002 Jul; 143(7):2673-9. PubMed ID: 12072401
    [Abstract] [Full Text] [Related]

  • 23. Expression and steroid hormonal control of Muc-1 in the mouse uterus.
    Surveyor GA, Gendler SJ, Pemberton L, Das SK, Chakraborty I, Julian J, Pimental RA, Wegner CC, Dey SK, Carson DD.
    Endocrinology; 1995 Aug; 136(8):3639-47. PubMed ID: 7628404
    [Abstract] [Full Text] [Related]

  • 24. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H, Conrad SE.
    Cancer Res; 2002 Jul 15; 62(14):3985-91. PubMed ID: 12124331
    [Abstract] [Full Text] [Related]

  • 25. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.
    Pederson TM, Kramer DL, Rondinone CM.
    Diabetes; 2001 Jan 15; 50(1):24-31. PubMed ID: 11147790
    [Abstract] [Full Text] [Related]

  • 26. Expression of insulin-like growth factor binding protein-4, insulin-like growth factor-I receptor, and insulin-like growth factor-I in the mouse uterus throughout the estrous cycle.
    Henemyre C, Markoff E.
    Mol Reprod Dev; 1999 Apr 15; 52(4):350-9. PubMed ID: 10092114
    [Abstract] [Full Text] [Related]

  • 27. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium.
    Adesanya OO, Zhou J, Bondy CA.
    J Clin Endocrinol Metab; 1996 May 15; 81(5):1967-74. PubMed ID: 8626866
    [Abstract] [Full Text] [Related]

  • 28. Effects of 9-ene-tetrahydrocannabinol on expression of beta-type transforming growth factors, insulin-like growth factor-I and c-myc genes in the mouse uterus.
    Das SK, Paria BC, Andrews GK, Dey SK.
    J Steroid Biochem Mol Biol; 1993 Jun 15; 45(6):459-65. PubMed ID: 8390853
    [Abstract] [Full Text] [Related]

  • 29. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo.
    Ohleth KM, Lenhart JA, Ryan PL, Radecki SV, Bagnell CA.
    Endocrinology; 1997 Sep 15; 138(9):3652-8. PubMed ID: 9275049
    [Abstract] [Full Text] [Related]

  • 30. Uterine insulin-like growth factor-I receptors: regulation by estrogen and variation throughout the estrous cycle.
    Ghahary A, Murphy LJ.
    Endocrinology; 1989 Aug 15; 125(2):597-604. PubMed ID: 2546740
    [Abstract] [Full Text] [Related]

  • 31. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
    Sahlin L, Masironi B, Akerberg S, Eriksson H.
    Reprod Biol Endocrinol; 2006 Sep 11; 4():47. PubMed ID: 16965620
    [Abstract] [Full Text] [Related]

  • 32. Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus.
    Ivanga M, Labrie Y, Calvo E, Belleau P, Martel C, Luu-The V, Morissette J, Labrie F, Durocher F.
    Physiol Genomics; 2007 Mar 14; 29(1):13-23. PubMed ID: 17361005
    [Abstract] [Full Text] [Related]

  • 33. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Pons S, White MF, Benito M.
    Mol Endocrinol; 1998 May 14; 12(5):688-97. PubMed ID: 9605931
    [Abstract] [Full Text] [Related]

  • 34. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun 14; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 35. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H, Aronica SM, Katzenellenbogen BS.
    Endocrinology; 1994 Feb 14; 134(2):658-64. PubMed ID: 7507831
    [Abstract] [Full Text] [Related]

  • 36. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 37. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice.
    Pete G, Fuller CR, Oldham JM, Smith DR, D'Ercole AJ, Kahn CR, Lund PK.
    Endocrinology; 1999 Dec 01; 140(12):5478-87. PubMed ID: 10579310
    [Abstract] [Full Text] [Related]

  • 38. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R, Haimsohn M, Wertheim N, Hemi R, Nir U, Karasik A, Kanety H, Geier A.
    Endocrinology; 2001 Jul 01; 142(7):3098-107. PubMed ID: 11416032
    [Abstract] [Full Text] [Related]

  • 39. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M, Vigouroux C, Desbois-Mouthon C, Deibener J, Kaminski P, Lascols O, Cherqui G, Capeau J, Caron M.
    J Clin Endocrinol Metab; 1999 Sep 01; 84(9):3197-206. PubMed ID: 10487687
    [Abstract] [Full Text] [Related]

  • 40. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
    Sun H, Baserga R.
    Endocrinology; 2004 Nov 01; 145(11):5332-43. PubMed ID: 15297443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.